Table 2

Summary of 13 patients with suspected lobular endocervical glandular hyperplasia who underwent immediate hysterectomy

CaseAgeMRI findingsCytology‘Yellow/orange’ mucinHIK1083 testCervical biopsy /ConizationMode of surgeryPathological diagnosis
1648CPNILM+NA/NATAHLEGH with atypia
1733MPAGC-NOS++LEGH with atypia/LEGH with atypiaTLHLEGH with atypia
1840CPNILM+LEGH/NATAH, BSOLEGH
1946CPNILMNA+Normal/NATAHLEGH
2057CPAGC-NOS++NA/NATAHLEGH
2142CCPAGC-NOS+NA/NATAHLEGH
2268CCPNILM++NA/NATAHLEGH
2347CCPNILM+Normal/NATAH, BSOLEGH
2453CPAGC-NOS++NA/LEGHTLH, BSOLEGH
2549MPAGC-NOS++CIN3, LEGH/NATAHCIN3, LEGH
2652CPAGC-NOS++AIS, LEGH/AIS, LEGHTLHAIS, LEGH
2753CPNILMNormal/NATLH, BSOTunnel cluster*
2848MPNILM+NA/NATAH, BSONC†
  • *With atypical polypoid adenomyoma.

  • †With endometrial carcinoma.

  • AGC-NOS, atypical glandular cells-not otherwise specified; AIS, adenocarcinoma in situ; BSO, bilateral salpingo-oophorectomy; CCP, coarse cystic pattern; CIN, cervical intraepithelial neoplasia; CP, cosmos pattern; LEGH, lobular endocervical glandular hyperplasia; MP, microcystic pattern; MRI, magnetic resonance imaging; NA, not available; NC, nabothian cyst; NILM, negative for intraepithelial lesion or malignancy; sLEGH, suspected lobular endocervical glandular hyperplasia; TAH, total abdominal hysterectomy; TLH, total laparoscopic hysterectomy.